Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2020-12-14Clinical Trial Update: A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 [Phase 3]
A Phase 3 trial of SPARC1507 in advanced biliary tract cancer has been withdrawn.
-
FDA approval · 2020-12-11FDA Approved: GEMCITABINE — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' generic gemcitabine hydrochloride under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line [Phase 2]
Phase 2 trial comparing mFOLFOX vs. mFOLFIRI in advanced or recurrent biliary tract cancer refractory to first-line therapy has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update evaluating varlitinib plus capecitabine in Chinese patients with advanced or metastatic biliary tract cancer h…
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating first-line gemcitabine, cisplatin, and MEK162 in advanced biliary tract carcinoma has completed with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer [Phase 2]
A Phase 2 clinical trial evaluating adjuvant immunotherapy in combination with chemoradiation for high-risk resectable biliary tract cancers…
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers [Phase 2]
Phase 2 study of nivolumab in patients with advanced refractory biliary tract cancers has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating anlotinib in combination with PD-1 inhibitor and gemcitabine plus cisplatin for unresectable or metastatic biliary …
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients [Phase 2, Phase 3]
A clinical trial update discusses evaluating surufatinib for biliary tract cancer across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers [Phase 3]
Phase 3 trial comparing active symptom control alone versus with mFOLFOX chemotherapy for locally advanced or metastatic biliary tract cance…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Single Agent Regorafenib in Refractory Advanced Biliary Cancers [Phase 2]
Phase 2 clinical trial evaluating single-agent regorafenib in refractory advanced biliary cancers has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen [Phase 2]
Phase 2 clinical trial evaluating Tripley monoclonal antibody combined with GEMOX as first-line treatment for advanced biliary tract tumors.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract Cancers [Phase 2]
Phase 2 trial evaluating nab-paclitaxel with cisplatin in advanced biliary tract cancers; efficacy and safety updates are reported.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer [Phase 1, Phase 2]
A two-phase clinical trial evaluating MEK162 in combination with capecitabine in biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer [Phase 2]
Phase 2 study of S-1 in combination with gemcitabine as first-line therapy for advanced biliary tract cancer completed.
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating toripalimab in combination with S1 and albumin-bound paclitaxel in advanced biliary tract cancer is ongoing with un…
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System [Phase 2]
Phase 2 trial evaluating an anti-HER2 therapy in HER2-positive metastatic cancers of the digestive system; status is not specified.
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC [Phase 1, Phase 2]
A phase I/II study evaluating a pan-immunotherapy regimen in patients with biliary tract cancer (BTC) is ongoing, with both phase 1 and phas…
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma [Phase 2]
Phase 2 trial investigating gemcitabine, irinotecan, and panitumumab in advanced/metastatic biliary tract adenocarcinoma completed with post…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma [Phase 3]
Phase 3 trial comparing GEMOX to XELOX in advanced biliary tract cancer; status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy [Phase 2]
Phase 2 trial evaluating XELOX in advanced biliary tract carcinoma after failure of gemcitabine-based chemotherapy.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-613 in advanced or metastatic biliary tract cancers, including cholangiocarcinoma and unresectable o…
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Study of Surufatinib as Second-line Treatment in Patients With Biliary Tract Carcinoma [Phase 2]
Phase 2 trial evaluating surufatinib as second-line therapy in biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating oral rehydration therapy to support short hydration during cisplatin plus gemcitabine chemotherapy in biliary tract…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer [Phase 3]
Phase 3 trial comparing gemcitabine/cisplatin/S-1 versus gemcitabine/cisplatin for biliary tract cancer has completed.